Issue 80, 2020

Facile one-pot synthesis of cyclic peptide-conjugated photosensitisers for targeted photodynamic therapy

Abstract

A novel synthetic strategy for in situ cyclisation of peptides and conjugation with functional boron dipyrromethenes (BODIPYs) has been developed. Linear peptides with up to 16 amino acid residues can be cyclised effectively and the resulting conjugates can be isolated in higher than 20% yield. One of the conjugates having a cyclic RGD moiety has been studied both in vitro and in vivo. It exhibits high and selective affinity towards the αvβ3-positive cell lines and induces high photocytotoxicity. The conjugate can also selectively localise in and effectively inhibit the growth of αvβ3-overexpressed tumour in vivo.

Graphical abstract: Facile one-pot synthesis of cyclic peptide-conjugated photosensitisers for targeted photodynamic therapy

Supplementary files

Article information

Article type
Communication
Submitted
02 août 2020
Accepted
07 sept. 2020
First published
07 sept. 2020

Chem. Commun., 2020,56, 11941-11944

Facile one-pot synthesis of cyclic peptide-conjugated photosensitisers for targeted photodynamic therapy

J. C. H. Chu, C. Yang, W. Fong, C. T. T. Wong and D. K. P. Ng, Chem. Commun., 2020, 56, 11941 DOI: 10.1039/D0CC05264G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements